Title: Study of Cerebral Venous Trombosis in Central India

Authors: Dr Vijay Kumar Nandmer, Dr Ajay Kumar Nandmer

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i2.91

Abstract

Thrombosis of the venous channels in the brain accounts for 0·5% of all stroke and is an uncommon cause of cerebral infarction relative to arterial disease but is an important consideration because of its potential morbidityThe aim of this study is to evaluate the D-Dimer as a screening tool for the diagnosis of cerebral venous thrombosis.

Aims and Objectives: To study the clinical characteristics, risk factors and outcome of cerebral venous thrombosis. To evaluate the role of D-Dimer in the diagnosis of cerebral venous thrombosis. To find co-relation if any between levels of D-Dimer, duration of symptoms and outcome of cerebral venous thrombosis.

Discussion

Epidemiology of Cerebral Venous Thromsosis

Age and Sex: In the present study the average age of presentation for patients with cerebral venous thrombosis was 29.79+SD 12.1414 years. The youngest patient was of 14 years while the oldest was of 63 years.

Clinical Features: In the present study headache was the most common symptom seen in 91.6% of all patients. Other symptoms include seizures (79%), focal nuerological deficit (50%), diffuse encephalopathy (29.1%), fever (29.1%), and dimunition of vision (8.3%).

Outcome: In the 24 patients evaluated in our study, 17 (70.83%) patients had complete recovery in 1 month whereas 5 (20.83%) had persistent deficit at the end of 1 month. Complete recovery at one month was seen in  80% of male patients and 78.95% in female patients. The mortality rate in our study of CVT was found to be 8.33%. Factors associated with increased mortality were presence of sepsis and seizures.

D-Dimer levels in cerebral venous thrombosis: In the present study the D-Dimer levels were found to be elevated in 22 out of the 24 patients evaluated. The mean value of D-Dimer for patients with cerebral venous thrombosis was found to be 1.815417 + SD 1.498352 mcg/ml and that of controls was found to be 0.41433 + SD 0.234403 mcg/ml. The difference between the values of cases and controls was found to be statistically significant with ‘p’ value < 0.001. Mean (cases)- Mean (controls) = 1.401054 with 95% confidence interval between 0.84 to 1.95708.

Summary & Conclusions: The present study evaluated 24 patients of Cerebral Venous Thrombosis and 30 age and sex matched controls. The risk factors, clinical presentations, and duration of symptoms of both the groups were determined. The level of D-dimer were determined for both cases and controls and its significance was tested by statistical analysis.

The mean age for cases of CVT in the present study was 29.79 years.

Females accounted for 79.16 % of cases and were affected at a younger age in comparision with males. The male: female ratio in the study was 1:3.8.

Average duration of symptoms before presentation in the present study was 5.67 + SD 4.26 days.

Headache and seizures were the most common clinical features of CVT.

In the present study, puerperium was the most common risk factor for the development of CVT.

D-Dimer levels were significantly elevated in patients of CVT as compared with controls (p< 0.001).

D-Dimer assay was found to have high sensitivity (91.66 %) in predicting the presence of CVT in the present study. The specificity, positive predictive value and negative predictive value of D-Dimer levels was found to be 80 %, 78.59% and 92.30 % respectively.

In the present study the sensitivity of D-dimer assay was highest when the test was applied early in the course of illness (100 %). The sensitivity of the test declined rapidly as the duration of symptoms prior to testing increased.

The present study supports the use of D-dimer as a ‘rule out’ test for CVT. The diagnosis of CVT is unlikely in the presence of a normal D-Dimer value. Patients with features of CVT with elevated D-Dimer should be urgently sent for MRV for confirmation of diagnosis. However the elevation of D-Dimer itself does not indicate presence of CVT. 

Keywords -cerebral venous thrombosis, D-dimer.

References

1.      Marie-Germaine Bousser, José M Ferro. Cerebral Venous Thrombosis: An Update. Lancet Neurol 2007; 6: 162–70

2.      Ribes MF. Des recherches faites sur la phlébite. Revue Médicale Française et Etrangère et Journal de Clinique de l’Hôtel-Dieu et de la Charité de Paris 1825; 3: 5–41.

3.      Nagaraja D, Tally AB. Stroke in the young in progress in Clinical Neurosciences Edt publ Sinha KK, Ranchi 1988; 2:129-45

4.      Chopra JS, Prabhakar S. Clinical features and risk factors in stroke in young. Acta Neurologica  Scandivia 1979; 43: 289-300

5.      Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10: 87–111

6.      Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338 (8767): 597–600

7.      Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results ofthe International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664–70

8.      Van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005; 65: 192–96.

9.      Adam SS, Key NS, Greenberg CS (March 2009). "D-dimer antigen: current concepts and future prospects". Blood 113 (13): 2878–87 Wells PS, Anderson DR, Rodger M, et al. (2003). "Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis". N. Engl. J. Med. 349 (13): 1227–35

10.  Wells PS, Anderson DR, Rodger M, et al. (2003). "Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis". N. Engl. J. Med. 349 (13): 1227–35

11.  Rathbun, SW; TL Whitsett, SK Vesely, GE Raskob (2004). "Clinical utility of D-dimer in patients with suspected pulmo-nary embolism and nondiagnostic lung scans or negative CT findings".  Chest  125 (3): 851–855. doi:10.1378/chest.125.3.851.  PMC 1215466.  PMID  15006941.

12.  Schrecengost JE, LeGallo RD, Boyd JC et al. (September 2003). "Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for the evaluation of suspected pulmonary embolism". Clinical Chemistry 49 (9): 1483-1490. doi:10.1373/49.9.1483.  PMID 12928229

13.  17th edition Harrison’s Principles Of Internal Medicine. Chapter  110, pg 729

14.  Consultative hemostasis and thrombosis By Craig S. Kitchens, Barbara M. Alving, Craig M. Kessle

15.  gates pc. Cerebral venous thrombosis: CMAJ  142 (3) 122-125; 1991.

Corresponding Author

Dr Ajay Kumar Nandmer